Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0001401
UniProt IDP80217
Primary gene name(s)IFI35
Synonym gene name(s)IFP35
Protein nameInterferon-induced 35 kDa protein
Protein functionNot yet known.
Subcellular locationNucleus. Note=Nuclear following IFN treatment.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: P80217
Gene Ontology
(Biological Process)
Complete annatation
type I interferon signaling pathway [GO:0060337]
Gene Ontology
(Molecular Function)
Complete annatation
unknown
Gene Ontology
(Cellular Component)
Complete annatation
cytosol [GO:0005829];
nucleus [GO:0005634]
Protein-protein interaction109656
Phylogenetic treeP80217
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
      unknown
Brass et al., Science, 2008
      unknown
Smith et al., J. Immunol, 2010
      unknown
Interferon-stimulated
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: 18.14708602; Folds changes 16h: 9.219260288; Tested: tested;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model


DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD30.9573346953237950.003901281403777210.011797775545291
AZA vs. DISU-0.22920130063940.5797945476453740.954982272511679
AZA vs. IL70.4286317193355960.06160072554338960.715888771099083
AZA vs. SAHA-1.117989172646450.005892523377844070.0688208961856386
DISU vs. CD3-1.198050770752920.00184294778054850.00698355828154552
DISU vs. IL70.6469460683454730.09886355211651880.417002811459575
DISU vs. SAHA-0.8852391002831090.09327512679858450.390160820422278
DMSO vs. AZA0.03669291377979490.8635716274605021
DMSO vs. CD3-0.9307535126935890.004024848066347730.0114081535502406
DMSO vs. DISU0.2641626301147090.486844216225610.904096406471958
DMSO vs. IL70.3991475220810040.03003906701782360.351583024296343
DMSO vs. SAHA-1.158394826756270.001740513792237610.0266037356620821
HIV vs. Mock in Activation0.166098391578870.7898708903784440.999983755607037
HIV vs. Mock in Latency0.04190245419160970.8041966312183680.999834320637052
IL7 vs. CD3-0.5247363234638980.1044997317510960.196203843632818
SAHA vs. CD3-2.095690148184321.8122300216028e-082.28156277573552e-07
SAHA vs. IL7-1.546318647255754.67386088216504e-050.00106425647942229
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
2.5 0.000123829 1.6 0.000345181 2.1 0.002963717
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) TRUE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 1.48201 0.000305467
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
0.204 2.37E-05

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
1 0.924 0.951 1.055 0.847
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
209417_s_at 1.82 Yes upregulated in CD4+ cells
209417_s_at 2.62 Yes upregulated in CD8+ cells

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

not found

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

HIV Partner Interaction Type PubMed
Tat modulates 24742347
Vpr upregulates 26116899
Tat upregulates 12539042
24742347

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
not found
Menu